[{"id":"65ca8a5e-0989-42c5-b8b3-bca3de969e16","acronym":"","url":"https://clinicaltrials.gov/study/NCT05981235","created_at":"2023-08-08T14:08:32.113Z","updated_at":"2025-02-25T15:01:02.369Z","phase":"Phase 1","brief_title":"Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors","source_id_and_acronym":"NCT05981235","lead_sponsor":"Peking University","biomarkers":" CLDN18","pipe":" | ","alterations":" CLDN18.2 expression","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CLDN18.2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AZD6422"],"overall_status":"Recruiting","enrollment":" Enrollment 96","initiation":"Initiation: 12/14/2023","start_date":" 12/14/2023","primary_txt":" Primary completion: 06/01/2026","primary_completion_date":" 06/01/2026","study_txt":" Completion: 11/01/2028","study_completion_date":" 11/01/2028","last_update_posted":"2024-01-01"}]